Irimia R - Search Results

1

Relevance of newly acquired mutations to the prognosis of patients with relapsed multiple myeloma.

Coriu D, Badelita S, Irimia R. Coriu D, et al. Among authors: irimia r. Pol Arch Intern Med. 2020 Jun 25;130(6):473-475. doi: 10.20452/pamw.15446. Epub 2020 Jun 25. Pol Arch Intern Med. 2020. PMID: 32588576 Free article. No abstract available.

2

Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study.

Janssens R, Lang T, Vallejo A, Galinsky J, Plate A, Morgan K, Cabezudo E, Silvennoinen R, Coriu D, Badelita S, Irimia R, Anttonen M, Manninen RL, Schoefs E, Vandebroek M, Vanhellemont A, Delforge M, Stevens H, Simoens S, Huys I. Janssens R, et al. Among authors: irimia r. Front Med (Lausanne). 2021 Jul 6;8:686165. doi: 10.3389/fmed.2021.686165. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34295912 Free PMC article.

3

Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.

Draghici M, Jercan A, Badelita SN, Irimia RM, Bastian AE, Dobrea C, Popescu M, Coriu D. Draghici M, et al. Among authors: irimia rm. Medicine (Baltimore). 2021 Dec 23;100(51):e28267. doi: 10.1097/MD.0000000000028267. Medicine (Baltimore). 2021. PMID: 34941106 Free PMC article.

4

Evans Syndrome as a Possible Complication of Brentuximab Vedotin Therapy for Peripheral T Cell Lymphoma.

Irimia R, Barbu S, Popa C, Badelita S. Irimia R, et al. Hematol Rep. 2023 Mar 22;15(1):220-224. doi: 10.3390/hematolrep15010023. Hematol Rep. 2023. PMID: 36975736 Free PMC article.

5

The Efficacy of Carfilzomib Treatment in Bortezomib-Refractory Patients-Real Life Experience in a Tertiary Romanian Hospital.

Irimia R, Badelita SN, Barbu S, Zidaru L, Carlan IL, Coriu D. Irimia R, et al. J Clin Med. 2024 Apr 9;13(8):2171. doi: 10.3390/jcm13082171. J Clin Med. 2024. PMID: 38673444 Free PMC article.

6

Complications of Brentuximab Therapy in Patients with Hodgkin's Lymphoma and Concurrent Autoimmune Pathology-A Case Series.

Preda OD, Bădeliță S, Ursuleac I, Irimia RM, Balanica S, Cojocaru M, Cotruta C, Dobrea C, Coriu D. Preda OD, et al. Among authors: irimia rm. Hematol Rep. 2024 May 20;16(2):299-307. doi: 10.3390/hematolrep16020030. Hematol Rep. 2024. PMID: 38804283 Free PMC article.

7

Determining diagnostic delays in Romanian multiple myeloma patients using the Aarhus statement.

Irimia R, Badelita S, Barbu S, Cirlan IL, Zidaru L, Coriu D. Irimia R, et al. Front Med (Lausanne). 2024 May 24;11:1372907. doi: 10.3389/fmed.2024.1372907. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38854669 Free PMC article.

8

Novel insights into the antiproliferative effects and synergism of quercetin and menadione in human leukemia Jurkat T cells.

Baran I, Ionescu D, Filippi A, Mocanu MM, Iftime A, Babes R, Tofolean IT, Irimia R, Goicea A, Popescu V, Dimancea A, Neagu A, Ganea C. Baran I, et al. Among authors: irimia r. Leuk Res. 2014 Jul;38(7):836-49. doi: 10.1016/j.leukres.2014.04.010. Epub 2014 May 4. Leuk Res. 2014. PMID: 24862793

9

Mitochondrial respiratory complex I probed by delayed luminescence spectroscopy.

Baran I, Ionescu D, Privitera S, Scordino A, Mocanu MM, Musumeci F, Grasso R, Gulino M, Iftime A, Tofolean IT, Garaiman A, Goicea A, Irimia R, Dimancea A, Ganea C. Baran I, et al. Among authors: irimia r. J Biomed Opt. 2013 Dec;18(12):127006. doi: 10.1117/1.JBO.18.12.127006. J Biomed Opt. 2013. PMID: 24365956 Free article.

10

Histone Deacetylase Inhibitors for Peripheral T-Cell Lymphomas.

Irimia R, Piccaluga PP. Irimia R, et al. Cancers (Basel). 2024 Sep 30;16(19):3359. doi: 10.3390/cancers16193359. Cancers (Basel). 2024. PMID: 39409979 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters